Login / Signup

Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.

Alexander E DrilonDaniel Shao-Weng TanUlrik N LassenSerge LeyvrazYongmei LiuJyoti D PatelLee S RosenBenjamin SolomonRicarda NorenbergLaura DimaNicoletta BregaLin ShenVictor MorenoShivaani KummarJessica J Lin
Published in: JCO precision oncology (2022)
fusions in patients with lung cancer.
Keyphrases
  • protein kinase
  • tyrosine kinase
  • binding protein